Anti-RGS17 antibodies are used in the immunodetection of the protein regulator of G protein signaling 17. In humans, the canonical protein has a reported length of 210 amino acid residues and a mass of 24.4 kDa. Its subcellular localization is in the membrane, nucleus, and cytoplasm. It is reported to be highly expressed in the the cerebellum. RGS17 is reported to regulate G protein-coupled receptor signaling cascades, including signaling via muscarinic acetylcholine receptor CHRM2 and dopamine receptor DRD2. Post-translational modifications have been described, including O-glycosylation, sumoylation and phosphorylation. Synonyms for this target antigen include RGSZ2 and hRGS17. RGS17 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Some RGS17 antibodies may have been used in research and have associated citations. These antibodies are most commonly used in Western Blot experiments, among other applications.